e-z cinnamic acid has been researched along with casein kinase ii in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bain, J; Cozza, G; Di Maira, G; Elliott, M; Meggio, F; Moro, S; Pagano, MA; Pinna, LA; Poletto, G; Ruzzene, M; Sarno, S; Zagotto, G | 1 |
1 other study(ies) available for e-z cinnamic acid and casein kinase ii
Article | Year |
---|---|
Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors.
Topics: Adenosine Triphosphate; Apoptosis; Binding Sites; Casein Kinase II; Cinnamates; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Jurkat Cells; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation | 2007 |